NewLink Genetics Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
31,180.00
102,858.00
40,381.00
85,155.00
71,951.00
53,595
Depreciation, Depletion & Amortization
891.00
1,097.00
1,592.00
2,084.00
1,407.00
1,145
Other Funds
4,367.00
8,613.00
15,940.00
20,268.00
18,634.00
17,222
Funds from Operations
25,922.00
112,568.00
22,849.00
62,803.00
51,910.00
35,228
Changes in Working Capital
104.00
3,500.00
1,238.00
3,144.00
3,629.00
2,711
Net Operating Cash Flow
25,818.00
109,068.00
24,087.00
65,947.00
48,281.00
37,939
Capital Expenditures
1,386.00
1,700.00
3,995.00
2,246.00
43.00
Sale of Fixed Assets & Businesses
-
-
-
-
254.00
Purchase/Sale of Investments
1,245.00
12,144.00
10,213.00
2,180.00
-
Net Investing Cash Flow
141.00
13,844.00
6,218.00
66.00
211.00
Issuance/Reduction of Debt, Net
215.00
90.00
194.00
257.00
246.00
Net Financing Cash Flow
67,000.00
33,889.00
23,085.00
1,883.00
75,288.00
Net Change in Cash
41,041.00
129,113.00
5,216.00
64,130.00
27,218.00
Free Cash Flow
27,204.00
107,368.00
28,082.00
68,193.00
48,324.00
Change in Capital Stock
67,215.00
33,979.00
23,279.00
2,140.00
75,534.00
About NewLink Genetics
View Profile
